Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 14Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Colorectal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 7Melanoma 6Pancreatic Neoplasms 5Neoplastic Cells, Circulating 4Hematologic Neoplasms 4Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Leukemia 3Glioblastoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2Sarcoma 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Liver Diseases 2Kidney Neoplasms 2Glioma 2

Interventions

mirabegron 1Papaverine 1Diclofenac 1Cystoscopy 1Catheters, Indwelling 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostatic Hyperplasia × Blood Specimen Collection × Clear all
NCT02940977 2018-07-10

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Unknown
120 enrolled
Genitourinary

Neoplastic Cells, Circulating, Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡